Trial Profile
Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients with Low Bone Mass
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Renal failure; Secondary hyperparathyroidism
- Focus Adverse reactions; Pharmacodynamics
- 27 Nov 2015 New trial record